Literature DB >> 15332399

Airway iron and iron-regulatory cytokines in cystic fibrosis.

D W Reid1, Q T Lam, H Schneider, E H Walters.   

Abstract

Iron availability is critical to Pseudomonas aeruginosa. The current authors determined sputum iron, ferritin, microalbumin levels and total cell counts (TCC) in 19 adult patients with cystic fibrosis (CF) during an acute exacerbation and repeated analyses following a median of 12 days antibiotic treatment. The current authors also determined sputum interleukin (IL)-1beta and tumour necrosis factor (TNF)-alpha levels because of their putative role in intracellular iron homeostasis. Additional data were obtained from 17 stable CF patients, eight patients with stable chronic obstructive pulmonary disease (COPD) and six normal subjects. Overall, sputum iron, ferritin, microalbumin, IL-1beta and TNF-alpha concentrations and TCCs were significantly elevated in the CF patients compared to those with COPD and normal controls. Sputum ferritin levels were significantly elevated in acute versus stable CF patients and there was a trend for sputum TCC to be higher, but all other inflammatory indices were similar. In the CF patients, sputum iron was positively and strongly related to IL-1beta, TNF-alpha, ferritin and microalbumin levels, but negatively related to forced expiratory volume in one second % predicted. In those acute patients who clinically improved with antibiotics (n=14), there were significant decreases in sputum TCC, iron, ferritin and IL-1beta content, but not TNF-alpha or albumin levels. However, changes in sputum TNF-alpha in acute patients were still closely related to changes in iron, ferritin and albumin content, and changes in IL-1beta were related to changes in sputum ferritin content. Iron and iron-regulatory cytokines may play a role in cystic fibrosis lung disease and the increased iron content may even facilitate Pseudomonas aeruginosa infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15332399     DOI: 10.1183/09031936.04.00104803

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

1.  Switching between apparently redundant iron-uptake mechanisms benefits bacteria in changeable environments.

Authors:  Zoé Dumas; Adin Ross-Gillespie; Rolf Kümmerli
Journal:  Proc Biol Sci       Date:  2013-06-12       Impact factor: 5.349

Review 2.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

3.  Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity.

Authors:  Matthew R Hendricks; Lauren P Lashua; Douglas K Fischer; Becca A Flitter; Katherine M Eichinger; Joan E Durbin; Saumendra N Sarkar; Carolyn B Coyne; Kerry M Empey; Jennifer M Bomberger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

4.  Ferritin and ferrihydrite nanoparticles as iron sources for Pseudomonas aeruginosa.

Authors:  Carolyn Dehner; Nydia Morales-Soto; Rabindra K Behera; Joshua Shrout; Elizabeth C Theil; Patricia A Maurice; Jennifer L Dubois
Journal:  J Biol Inorg Chem       Date:  2013-02-16       Impact factor: 3.358

5.  What is hepcidin telling us about the natural history of cystic fibrosis?

Authors:  A H Gifford
Journal:  J Cyst Fibros       Date:  2014-04-30       Impact factor: 5.482

6.  Iron and CF-related anemia: expanding clinical and biochemical relationships.

Authors:  A H Gifford; S D Miller; B P Jackson; T H Hampton; G A O'Toole; B A Stanton; H W Parker
Journal:  Pediatr Pulmonol       Date:  2010-10-20

7.  The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa.

Authors:  Amanda G Oglesby-Sherrouse; Louise Djapgne; Angela T Nguyen; Adriana I Vasil; Michael L Vasil
Journal:  Pathog Dis       Date:  2014-02-10       Impact factor: 3.166

8.  Iron homeostasis during cystic fibrosis pulmonary exacerbation.

Authors:  Alex H Gifford; Lisa A Moulton; Dana B Dorman; Gordana Olbina; Mark Westerman; H Worth Parker; Bruce A Stanton; George A O'Toole
Journal:  Clin Transl Sci       Date:  2012-06-01       Impact factor: 4.689

Review 9.  Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.

Authors:  Jean Tyrrell; Máire Callaghan
Journal:  Microbiology (Reading)       Date:  2015-12-04       Impact factor: 2.777

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.